Abstract
Gene deletion or gene amplification acts as a driving factor of onset, progress, and metastasis in various cancers, including ovarian cancers. By mining the whole genome data of ovarian cancer patients, we identify the long noncoding RNA PVT1 as the most amplified gene. Knockdown of PVT1 was then achieved using a shRNA in two ovarian cancer cell lines, and cell viability was determined by trypan blue exclusion assay, cell metabolism by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide assay, and cell cycle alteration by propidium iodide cell cycle analysis. Potential targeting microRNAs were predicted with starBase v2.0, and direct binding of miR-140 on PVT1 was confirmed by luciferase reporter assay and microRNA pull-down assay. Evolutionary conserved transcription factor-binding site was predicted via rVista 2.0. Our results show that PVT1 was the most amplified gene in ovarian cancer patients, and it was highly correlated with poor survival outcomes. Knockdown of PVT1 caused decreased cell viability, metabolic activity, and smaller proportion of S-phase cells. PVT1 directly bound to miR-140 and acted as a microRNA sponge, while transcription of PVT1 was regulated by the transcription factor FOXO4. In conclusion, viability, metabolism, and cell cycle of ovarian cancers are regulated by the FOXO4/PVT1/miR-140 signaling pathway.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cahill DP, Kinzler KW, Vogelstein B, Lengauer C (1999) Genetic instability and darwinian selection in tumours. Trends Cell Biol 9:M57–M60
Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401–404. https://doi.org/10.1158/2159-8290.CD-12-0095
Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S (2017) UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19:649–658. https://doi.org/10.1016/j.neo.2017.05.002
Chen Y, Du H, Bao L, Liu W (2018) LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214. Cancer Biol Med 15:238–250. https://doi.org/10.20892/j.issn.2095-3941.2017.0174
Doubeni CA, Doubeni AR, Myers AE (2016) Diagnosis and management of ovarian cancer. Am Fam Physician 93:937–944
Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1. https://doi.org/10.1126/scisignal.2004088
Guan Y, Kuo WL, Stilwell JL, Takano H, Lapuk AV, Fridlyand J, Mao JH, Yu M, Miller MA, Santos JL, Kalloger SE, Carlson JW, Ginzinger DG, Celniker SE, Mills GB, Huntsman DG, Gray JW (2007) Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 13:5745–5755. https://doi.org/10.1158/1078-0432.CCR-06-2882
He Y, Jing Y, Wei F, Tang Y, Yang L, Luo J, Yang P, Ni Q, Pang J, Liao Q, Xiong F, Guo C, Xiang B, Li X, Zhou M, Li Y, Xiong W, Zeng Z, Li G (2018) Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma. Cell Death Dis 9:235. https://doi.org/10.1038/s41419-018-0265-y
Hosaka T, Biggs WH 3rd, Tieu D, Boyer AD, Varki NM, Cavenee WK, Arden KC (2004) Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci USA 101:2975–2980. https://doi.org/10.1073/pnas.0400093101
Hsu RJ, Yang HJ, Tsai HJ (2009) Labeled microRNA pull-down assay system: an experimental approach for high-throughput identification of microRNA-target mRNAs. Nucleic Acids Res 37:e77. https://doi.org/10.1093/nar/gkp274
Ke Y, Zhao W, Xiong J, Cao R (2013) miR-149 inhibits non-small-cell lung cancer cells EMT by targeting FOXM1. Biochemi Res Int 2013:506731. https://doi.org/10.1155/2013/506731
Kruger J, Rehmsmeier M (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34:W451–W454. https://doi.org/10.1093/nar/gkl243
Li JH, Liu S, Zhou H, Qu LH, Yang JH (2014) starBase v2.0: decoding miRNA–ceRNA, miRNA–ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42:D92–D97. https://doi.org/10.1093/nar/gkt1248
Li H, Ouyang R, Wang Z, Zhou W, Chen H, Jiang Y, Zhang Y, Liao M, Wang W, Ye M, Ding Z, Feng X, Liu J, Zhang B (2016) miR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4. Sci Rep 6:39001. https://doi.org/10.1038/srep39001
Liu E, Liu Z, Zhou Y (2015a) Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1. Int J Clin Exp Pathol 8:3803–3810
Liu E, Liu Z, Zhou Y, Mi R, Wang D (2015b) Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways. Int J Clin Exp Med 8:20565–20572
Loots GG, Ovcharenko I (2004) rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res 32:W217–W221. https://doi.org/10.1093/nar/gkh383
Negrini S, Gorgoulis VG, Halazonetis TD (2010) Genomic instability: an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11:220–228. https://doi.org/10.1038/nrm2858
Orth K, Hung J, Gazdar A, Bowcock A, Mathis JM, Sambrook J (1994) Genetic instability in human ovarian cancer cell lines. Proc Natl Acad Sci USA 91:9495–9499. https://doi.org/10.1073/pnas.91.20.9495
Paraskevopoulou MD, Hatzigeorgiou AG (2016) Analyzing miRNA–LncRNA interactions. Methods Mol Biol 1402:271–286. https://doi.org/10.1007/978-1-4939-3378-5_21
Previs RA, Sood AK, Mills GB, Westin SN (2016) The rise of genomic profiling in ovarian cancer. Expert Rev Mol Diagn 16:1337–1351. https://doi.org/10.1080/14737159.2016.1259069
Quinn JJ, Chang HY (2016) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17:47–62. https://doi.org/10.1038/nrg.2015.10
Reid BM, Permuth JB, Sellers TA (2017) Epidemiology of ovarian cancer: a review. Cancer Biol Med 14:9–32. https://doi.org/10.20892/j.issn.2095-3941.2016.0084
Richards JS, Sharma SC, Falender AE, Lo YH (2002) Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins. Mol Endocrinol 16:580–599. https://doi.org/10.1210/mend.16.3.0806
Roupe KM, Veerla S, Olson J, Stone EL, Sorensen OE, Hedrick SM, Nizet V (2014) Transcription factor binding site analysis identifies FOXO transcription factors as regulators of the cutaneous wound healing process. PLoS ONE 9:e89274. https://doi.org/10.1371/journal.pone.0089274
Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB, Ball DW (2001) Notch signaling induces cell cycle arrest in small cell lung cancer cells. Can Res 61:3200–3205
Strober W (2001) Trypan blue exclusion test of cell viability. Curr Protoc Immunol. https://doi.org/10.1002/0471142735.ima03bs21
Sun Y, Zhang P, Pan XF, Zhang DY, Qiu W, Wang P (2016) Effects of Sp1 on the basic transcriptional activity of intestinal trefoil factor promoter. Chin J Burns 32:413–417. https://doi.org/10.3760/cma.j.issn.1009-2587.2016.07.006
Uhlenhaut NH, Treier M (2011) Forkhead transcription factors in ovarian function. Reproduction 142:489–495. https://doi.org/10.1530/REP-11-0092
Wang T, Wang G, Zhang X, Wu D, Yang L, Hao D (2017a) The expression of miRNAs is associated with tumour genome instability and predicts the outcome of ovarian cancer patients treated with platinum agents. Sci Rep 7:14736. https://doi.org/10.1038/s41598-017-12259-w
Wang Y, Kang XL, Zeng FC, Xu CJ, Zhou JQ, Luo DN (2017b) Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer. Pathol Res Pract 213:766–772. https://doi.org/10.1016/j.prp.2017.04.004
Weigel D, Jurgens G, Kuttner F, Seifert E, Jackle H (1989) The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 57:645–658
Xu CZ, Jiang C, Wu Q, Liu L, Yan X, Shi R (2016) A feed-forward regulatory loop between HuR and the long noncoding RNA HOTAIR promotes head and neck squamous cell carcinoma progression and metastasis. Cell Physiol Biochem 40:1039–1051. https://doi.org/10.1159/000453160
Yang Q, Yu Y, Sun Z, Pan Y (2018) Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer. Biomed Pharmacother 106:61–67. https://doi.org/10.1016/j.biopha.2018.06.112
Zhang P, Cao L, Fan P, Mei Y, Wu M (2016) LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses glycolysis by promoting Fbxw7-mediated c-Myc degradation. EMBO Rep 17:1204–1220. https://doi.org/10.15252/embr.201642067
Zhou S, Wang L, Yang Q, Liu H, Meng Q, Jiang L, Wang S, Jiang W (2018) Systematical analysis of lncRNA–mRNA competing endogenous RNA network in breast cancer subtypes. Breast Cancer Res Treat 169:267–275. https://doi.org/10.1007/s10549-018-4678-1
Zou MF, Ling J, Wu QY, Zhang CX (2018) Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2. Eur Rev Med Pharmacol Sci 22:7183–7188. https://doi.org/10.26355/eurrev_201811_16251
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
The study was approved by the Second People’s Hospital of Hefei, Anhui Medical University Affiliated Hefei Hospital.
Informed consent
All participants signed written consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ding, Y., Fang, Q., Li, Y. et al. Amplification of lncRNA PVT1 promotes ovarian cancer proliferation by binding to miR-140. Mamm Genome 30, 217–225 (2019). https://doi.org/10.1007/s00335-019-09808-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-019-09808-1